Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986 Jun;79(6):323–325. doi: 10.1177/014107688607900604

Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease.

J W Ramsay, W F Hendry
PMCID: PMC1290338  PMID: 3723531

Abstract

Serum parathyroid hormone (PTH) levels have been measured in 8 patients with hypercalcaemia associated with urological malignancy: 3 renal cell carcinomas, 2 adenocarcinomas of prostate, 2 transitional cell carcinomas of bladder and one transitional cell carcinoma of kidney. Five (63%) of these 8 patients had bone metastases. PTH was detectable in the serum of all 8 hypercalcaemic patients, but in only 2 cases was the PTH level above the normal range, and in one of these a coincidental parathyroid adenoma was found to be responsible for the hypercalcaemia. It appears that these tumours can produce a hormone-like substance with biological effects similar to PTH.

Full text

PDF
323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenner D. E., Harvey H. A., Lipton A., Demers L. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy. Cancer. 1982 Feb 1;49(3):556–561. doi: 10.1002/1097-0142(19820201)49:3<556::aid-cncr2820490327>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  2. COPE O., BARNES B. A., CASTLEMAN B., MUELLER G. C., ROTH S. I. Vicissitudes of parathyroid surgery: trials of diagnosis and management in 51 patients with a variety of disorders. Ann Surg. 1961 Oct;154:491–508. doi: 10.1097/00000658-196110000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chambers T. J. The pathobiology of the osteoclast. J Clin Pathol. 1985 Mar;38(3):241–252. doi: 10.1136/jcp.38.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horiuchi N., Holick M. F., Potts J. T., Jr, Rosenblatt M. A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science. 1983 Jun 3;220(4601):1053–1055. doi: 10.1126/science.6302844. [DOI] [PubMed] [Google Scholar]
  5. Ralston S., Fogelman I., Gardner M. D., Boyle I. T. Hypercalcaemia and metastatic bone disease: is there a causal link? Lancet. 1982 Oct 23;2(8304):903–905. doi: 10.1016/s0140-6736(82)90868-6. [DOI] [PubMed] [Google Scholar]
  6. Seyberth H. W., Segre G. V., Morgan J. L., Sweetman B. J., Potts J. T., Jr, Oates J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. doi: 10.1056/NEJM197512182932502. [DOI] [PubMed] [Google Scholar]
  7. Tashjian A. H., Jr Role of prostaglandins in the production of hypercalcemia by tumors. Cancer Res. 1978 Nov;38(11 Pt 2):4138–4141. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES